News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Clinical - Drug Product News
ANI Pharmaceuticals, Inc. Announces The Launch Of Etodolac 300mg Capsules 1/30/2015
CytoSorbents, Inc. And Aferetica Introduce CytoSorb® To Italy 1/30/2015
FDA Grants QIDP Designation To Neutrolin®, CorMedix (CRMD)'s Lead Product Candidate In The U.S. 1/29/2015
Merck & Co. (MRK)'s Fake MMR Trial Data Buried Even as Measles Outbreak Shows Vaccine Surge 1/28/2015
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market 1/28/2015
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co. (MRK) 1/28/2015
Rhinomed (ASX:RNO) Release Of Next Generation Turbine Sports Technology 1/28/2015
BioSpace (DHX) Poll Finds Whopping 92% of Respondents Believe Discounts Were Offered in Pricing War 1/27/2015
MSF Not Impressed With Pfizer (PFE)'s "Tiny" Vaccine Price Cut 1/27/2015
New England Biolabs Releases Rapid PNgase F For Biotherapeutic Development And Production 1/27/2015
IMPAX Laboratories, Inc. (IPXL) Receives FDA Approval For A Generic Version Of Lamictal® Orally Disintegrating Tablets (ODT) 1/26/2015
Purdue Pharma L.P. Release: Hysingla™ ER (hydrocodone bitartrate) Extended-Release Tablets CII Now Available 1/26/2015
Pfanstiehl Laboratories Launches New cGMP-produced, Parenteral Grade Maltose For Pharmaceutical Formulations 1/26/2015
Bogus Versions of Eli Lilly (LLY)'s Cialis Found Entering the U.S. By Mail, Says FDA 1/23/2015
After Gilead Sciences, Inc. (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next 1/23/2015
NanoViricides, Inc. (NNVC.PK) Reports That It Has Shipped anti-Ebola Drug Candidates For Testing to a BSL-4 Hi-Security Biocontainment Laboratory 1/22/2015
Disneyland Measles Outbreak Casts Shadow on Anti-Vaccination Movement 1/21/2015
Boehringer Ingelheim Pharmaceuticals, Inc. Release: SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available In The United States 1/21/2015
International Charity Slams GlaxoSmithKline (GSK), Pfizer (PFE) for High Vaccine Prices 1/20/2015
IDEXX Laboratories, Inc. (IDXX) Announces SDMA As Important Expansion To Reference Lab Test Menu 1/19/2015
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipment Of Generic Isradipine Capsules 1/16/2015
Mylan Inc. (MYL) Launches Generic Epivir-HBV® Tablets 1/16/2015
J.P. Morgan: AbbVie (ABBV) Getting "Very Compelling" Exclusive Offers for Viekira Pak, Says CFO 1/15/2015
Targets Of Next Express Scripts Inc. Price War: Amgen (AMGN) and Regeneron (REGN) 1/14/2015
Alimera Sciences (ALIM) Announces First Sale Of ILUVIEN® In Portugal 1/14/2015
Eli Lilly (LLY) Claims Innocence as FDA Bans Mystery Cialis-Viagra Concoction Discovered at Plant 1/14/2015
Breaking: J.P. Morgan: Sanofi (SAN.PA) Says Afrezza Will Be Available in 2015, Snubs MannKind Corporation (MNKD) CEO Retirement News 1/13/2015
Frost & Sullivan Releases Drug Launch And Phase 3 Trial Watch List For Top Therapeutic Areas 1/13/2015
Gilead Sciences, Inc. (GILD) Throws Another Punch at AbbVie (ABBV) by Striking Deal With Anthem, Inc. 1/12/2015
U.K. Cancer Drugs Fund Delists Big Pharmas' Meds; Novartis AG (NVS) Slams Process 1/12/2015
Hikma Pharmaceuticals (HIK.L) To Launch Colchicine 0.6mg Capsules 1/12/2015
HUYA Bioscience International Announces Regulatory Approval Of Chidamide, The First Selective HDAC Inhibitor In China 1/12/2015
Perrigo Company (PRGO) Launches The Generic Version Of Clobex® (Clobetasol Propionate) Spray, 0.05% 1/12/2015
Perrigo Company (PRGO) Launches AB Therapeutic Equivalent Testosterone Gel 1.0% 1/12/2015
Life Extension Introduces Immune Senescense Protection Formula 1/12/2015
Afaxys Announces Nationwide Availability Of Tarina Fe 1/20 To The Public Health Sector, Colleges & Universities 1/12/2015
Bioo Scientific Corporation Releases 18S ITS rRNA Library Prep Kit To Simplify Eukaryotic Metagenomic Studies 1/9/2015
Impax Pharmaceuticals (IPXL) Announce FDA Approval Of RYTARY™ (Carbidopa And Levodopa) Extended-Release Capsules For The Treatment Of Parkinson's Disease 1/8/2015
Gilead Sciences, Inc. (GILD) Fights Back as CVS Will Exclusively Cover Hepatitis C Drug Harvoni 1/7/2015
Lyophilization Services of New England Receives Approval To Manufacture Commercial Aseptic Product 1/7/2015
Teva Pharmaceutical Industries Limited (TEVA) Launches Generic Diovan® In The United States 1/7/2015
Fresenius Kabi AG Introduces NAROPIN® In Freeflex® Bag 1/6/2015
Lupin Ltd. (LUPN.BO) Launches Generic DIOVAN® Tablets 1/6/2015
NovaBay Pharmaceuticals, Inc. (NBY) Rebrands Its i-Lid Cleanser As Avenova 1/5/2015
Galderma Laboratories Launches Its First Over-The-Counter Acne Regimen, Benzac® Acne Solutions 1/5/2015
Mylan Inc. (MYL) Launches Generic Diovan® Tablets 1/5/2015
Newly-Approved Keryx Biopharmaceuticals (KERX) Drug Poised to Take About $600 Million of Genzyme Corporation (GENZ)'s Sales 1/2/2015
Sagent Pharmaceuticals, Inc. Announces The Launch Of Colistimethate For Injection, USP 12/30/2014
Novo Nordisk A/S (NVO) Plans to Use 500 Sales Reps to Promote New Obesity Drug 12/30/2014
UK Agency's Rejection of Eli Lilly (LLY), GlaxoSmithKline (GSK), PharmaMar S.A.'s Ovarian Cancer Drugs Stand 12/24/2014
Express Scripts Inc. Turns to AbbVie (ABBV) In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc. (GILD) 12/24/2014
PuraMed BioScience Nears Final Stages Needed For Distribution Of MigraPure H 12/23/2014
Keryx Biopharmaceuticals (KERX) Announces Commercial Launch Of AURYXIA™ (Ferric Citrate) Tablets In The United States 12/22/2014
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi) 12/22/2014
Mylan Inc. (MYL) Launches First Generic Version Of Vivelle-DOT® 12/22/2014
Amgen (AMGN)'s Blincyto To Carry A Hefty $178,000 Price Tag 12/19/2014
NovoCure Ltd. Announces Optune Now Available At More Than 150 Leading Cancer Centers Across The United States 12/19/2014
NVN Therapeutics Launches Estracool™ Dietary Supplement For Reduction Of Menopausal Symptoms 12/18/2014
Putney, Inc. Launches Carprofen Chewable Tablets 12/18/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Valganciclovir Tablets, USP 12/16/2014
Actavis (ACT) Ordered To Keep Selling Alzheimer's Pill 12/12/2014
Pacira Pharmaceuticals, Inc. (PCRX) Announces Changes To EXPAREL® Label 12/12/2014
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech (RHHBY) Consultants 12/11/2014
Abbott Laboratories (ABT)'s Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe 12/11/2014
Mylan Inc. (MYL) Launches First Generic Version Of Orapred ODT 12/11/2014
Mylan Inc. (MYL) Launches Generic Robaxin Injection 12/11/2014
Lupin Ltd. (LUPN.BO) Launches Authorized Genericfor Celebrex Capsules 12/11/2014
Mylan Inc. (MYL) Launches One Of First Available Generic Versions Of Celebrex Capsules 12/10/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of First Generic Celebrex® Capsules In The United States 12/10/2014
Actavis (ACT) Launches Generic Version Of Celebrex 12/10/2014
S.F. Men Shed Condoms In Favor Of Gilead Sciences, Inc. (GILD)'s HIV Prevention Pill Truvada 12/9/2014
BioPharmX Corporation Release: Introducing Violet Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort* 12/9/2014
ConvaTec Introduces Sensi-Care Clear Zinc Skin Protectant For Diaper Rash 12/9/2014
Ignyta (RXDX) Receives Approval Of Nonproprietary Name Entrectinib For Lead Product Candidate, RXDX-101 12/9/2014
BioPharmX Corporation Release: Introducing Violet™ Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort 12/9/2014
Zydus Cadila Launches World's First Biosimilar Of AbbVie (ABBV)'s Humira In India 12/9/2014
Daiichi Sankyo, Inc. (4568.t) Launches New Formulation Of LIXIANA 60 mg Tablets (edoxaban) In Japan 12/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: U.S. FDA Approves The Labeling Update Of Abilify Maintena® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia 12/8/2014
Basilea Pharmaceutica (BSLN.SW) Announces Launch Of Antibiotic Zevtera(R) (Ceftobiprole Medocaril) In Germany 12/5/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved In Germany 12/4/2014
PTC Therapeutics, Inc. (PTCT) Announces Launch Of Translarna (ataluren) In Germany 12/3/2014
Galderma Laboratories, L.P. Release: The Cetaphil® Brand Launches New Cetaphil® Baby Line 12/3/2014
Suneva Medical Release: Bellafill To Replace ArteFill As New Brand 12/2/2014
EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches In India 12/2/2014
Pfanstiehl Laboratories Launches cGMP-Produced, Parenteral Grade Mannitol For Pharmaceutical Formulations 12/2/2014
Catylix And Aspira Scientific Launch The First Reagent For Pentafluoroethylation 12/2/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Exforge HCT® Tablets In The United States 12/1/2014
SkyePharma Inc. (SKYE)’s Partner Kyorin Pharmaceutical Co., Ltd. Launches 120-Puff Version Of Flutiform In Japan 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
Actavis (ACT) Launches Generic Version Of Intuniv 12/1/2014
FDA Warning: PML Death Associated With Biogen Idec (BIIB)'s Tecfidera 11/26/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Docetaxel Injection USP 11/24/2014
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03% 11/24/2014
Sanofi (SAN.PA) Aims To Launch 18 New Drugs By 2020 11/21/2014
ViaDerma Lead Product TetraStem Shows Promise in Treating Acne 11/21/2014
IntelliPharmaCeutics Notes Launch Of 5mg Strength Of Focalin XR(R) Generic By Teva Pharmaceutical Industries Limited (TEVA) 11/20/2014
Endo International plc (ENDP) Announces Launch Of Generic Version Of Valcyte 11/20/2014
Amneal Pharmaceuticals Launches AG For Novo Nordisk A/S (NVO)’s Activella® 11/20/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Over-The-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets 11/20/2014
Keryx Biopharmaceuticals (KERX) Announces Trade Name Auryxia for Ferric Citrate 11/19/2014
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014
Pfizer (PFE) Release: TRUMENBA® (Meningococcal Group B Vaccine) Is Now Available 11/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches Liquid Formulation Of TREANDA® (bendamustine HCI) Injection In U.S. 11/18/2014
Organovo Announces Commercial Release Of The exVive3D™ Human Liver Tissue 11/18/2014
Peli Biothermal Coolpall Vertos Launch Success In Europe 11/18/2014
Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex/ 11/18/2014
Galderma Laboratories Release: The Cetaphil® Brand Revamps RestoraDerm® Product Line 11/17/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014
Mallinckrodt Pharmaceuticals (MNK) Responds To FDA’s Expected Reclassification Of Methylphenidate ER 11/14/2014
Kremers Urban Pharmaceuticals Inc. Informed By U.S. FDA Of ANDA Reclassification Of Methylphenidate ER 11/14/2014
Hep C King Gilead Sciences, Inc. (GILD)'s Harvoni Prescriptions Are Breaking Records 11/13/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes 11/13/2014
Five Percent Of Medicines In Malaysia Are Counterfeit: Pfizer (PFE) 11/11/2014
Oculus Innovative Sciences, Inc. (OCLS) Commercializes Microcyn®-Based Solution And Hydrogel For Treatment Of Mild-To-Moderate Acne In Europe 11/11/2014
Babies Die While Officials Haggle With Novartis AG (NVS) Over Cost Of Bexsero Vaccine 11/11/2014
Afaxys Pharmaceuticals Announces Wider National Availability Of ella® Emergency Contraceptive 11/11/2014
Endo Pharmaceuticals (ENDP) Receives Final Approval For Generic Version Of Valcyte® 11/10/2014
Eli Lilly (LLY)'s Trulicity™ (dulaglutide) Now Available In U.S. Pharmacies 11/10/2014
Tetrastem, Lead Product Of ViaDerma, Hopes To Slow Rates Of Diabetic Amputations 11/7/2014
ANI Pharmaceuticals, Inc. Announces The Launch Of Methazolamide Tablets USP 11/6/2014
Hospira, Inc. Announces U.S. Launch of Generic Paricalcitol Injection 11/6/2014
Mylan Inc. (MYL) Launches Generic Loestrin 24 Fe® 11/5/2014
Ranbaxy Laboratories (RANBAXY.BO) Receives Approval From FDA To Market Fenofibrate Capsules USP, 43 mg And 130 mg 11/5/2014
McNeil-PPC, Inc. Release: First FDA-Approved, Once Daily Application 5% Minoxidil Formula For Women Hits The Market 11/4/2014
Inergetics, Inc.' OmEssentials® Supplements Line Available At Whole Foods This Fall 11/4/2014
BioDelivery Sciences International (BDSI) Announces The Availability Of BUNAVAIL™ In The U.S. 11/3/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Belgium By Sandoz, Inc. 11/3/2014
Pharming Group (PHGUF.PK) And Salix Pharmaceuticals, Ltd. (SLXP) Announce The Launch Of Ruconest® In The U.S. For The Treatment Of Acute Angioedema Attacks In Patients With Hereditary Angioedema (HAE) 11/3/2014
Express Scripts Inc. Says AbbVie (ABBV)'s Drug Could Displace Gilead Sciences, Inc. (GILD)'s Sovaldi On Formulary 10/31/2014
Migranade, Inc. Release: Game Changing Migraine Medication To Be Available November 2014 10/31/2014
Omeros Corporation (OMER) Release: Omidria™ Granted Pass-Through Reimbursement Status From CMS 10/30/2014
Mylan Inc. (MYL) Launches Generic Viramune XR® 10/30/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
Novo Nordisk A/S (NVO) Announces U.S. Launch Of NovoFine® Plus, A New Pen Needle For Patients With Diabetes 10/29/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Sirolimus Tablets, 1 mg And 2 mg 10/29/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Fresenius Kabi AG Launches Kabiven® In The United States 10/27/2014
Octapharma AG Announces Octagam® 10% Now Available For Ordering In U.S. 10/27/2014
Pelvalon Announces New Analysis From The LIFE Pivotal Trial At The 2014 ICS Conference And Unveils The Brand Name For Its Vaginal Bowel Control Therapy 10/24/2014
European Medicines Agency Completes Review Of Polymyxin-Based Medicines 10/24/2014
BioSpace’s Favorite FDA Tricks Or Treats 10/24/2014
FDA Release: Gilead Sciences, Inc. (GILD)'s Harvoni® (ledipasvir/sofosbuvir) Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute 10/23/2014
Tekmira (TKMR) Provides Periodic Update On TKM-Ebola Program 10/22/2014
Gilead Sciences, Inc. (GILD)'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons 10/21/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Release: OFEV® (nintedanib) Now Available In The United States 10/21/2014
Government Of Canada Ships NewLink Genetics' Ebola Vaccine To The WHO 10/20/2014
U.S. Regulators Ask Three Labs For Mapp Biopharmaceutical's ZMapp Ebola Plans 10/20/2014
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014
Baxter International, Inc. (BAX) Launches HYQVIA In The United States For Adult Patients With Primary Immunodeficiency 10/20/2014
Admedus Cardiocel® To Be Launched In Canada 10/20/2014
Gilead Sciences, Inc. (GILD) Nervous As Johnson & Johnson (JNJ) Looks To Remain Competitive In Hepatitis C Market 10/16/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg 10/14/2014
Chimerix, Inc. (CMRX) Slips As Ebola Patient On Brincidofovir Dies 10/13/2014
PuraMed BioScience Nears Completion Of A Hemp-Derived-Cannabinoid-Based Non-Prescription Medication For Treatment Of Epilepsy Symptoms 10/13/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
Orexo AB (ORXOF) Submits Application To FDA For Expanded Label Of ZUBSOLV® 10/13/2014
Purdue Pharma L.P. Commercially Launches Recently Approved 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII 10/9/2014
Fujifilm Diosynth Biotechnologies Announces The Launch Of Its ‘Apollo™’ Mammalian Expression Platform 10/9/2014
Gilead Sciences, Inc. (GILD)'s Solvadi May Be Barred From UK's Service Plan 10/9/2014
Boehringer Ingelheim Corporation Release: New COPD Maintenance Treatment Striverdi® Respimat® (olodaterol) Inhalation Spray Now Available in U.S. Pharmacies 10/8/2014
Mylan Inc. (MYL) Launches Generic Combivir® 10/6/2014
Medac Pharma, Inc.'s Rasuvo (methotrexate) Injection Now Available For Patients With Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis 10/6/2014
Ashland Inc.  (ASH) Announces Global Price Increase For Vinyl Pyrrolidone- And Cellulosic-Based Pharmaceutical Excipient Products 10/6/2014
AstraZeneca PLC (AZN) Release: BRILINTA Preferred Over Clopidogrel In 2014 American Heart Association/American College of Cardiology Guideline For The Management Of Non–ST-Elevation Acute Coronary Syndromes 10/6/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To Patients Infected With Ebola Virus 10/6/2014
Diploma PLC (DPLM.L) Release: Otezla® (apremilast) Receives Expanded Indication; Diplomat To Distribute 10/2/2014
Ranbaxy Laboratories (RANBAXY.BO) Launches ABSORICA® (isotretinoin) 25 Mg And 35 Mg Capsules In The U.S. Market 10/1/2014
Prollenium Medical Technologies Release: Lyracaine Topical Anesthetic Now Approved For Sale In Canada 10/1/2014
Pfizer (PFE) Starts New Viagra Commercials Targeting Women 9/30/2014
Mapp Biopharmaceutical's Ebola Drug Production Set for Texas, Possibly North Carolina 9/30/2014
Inergetics, Inc. Introduces Surgex® Warrior Sports Nutrition At Winn-Dixie 9/30/2014
LEO Pharma Announced New Taclonex® (Calcipotriene And Betamethasone Dipropionate) Topical Suspension, 0.005%/0.064% Indication For Treatment Of Scalp Plaque Psoriasis In Pediatric Patients Ages 12-17 9/30/2014
Par Pharmaceutical, Inc. Begins Shipment of Generic Exforge® 9/30/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat 9/29/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season 9/29/2014
Jaguar Animal Health, Inc. Launches First Product, Neonorm™ Calf, At World Dairy Expo 9/29/2014
Actavis (ACT) Will Keep Selling Alzheimer's Drug In U.S. For 60 Days 9/26/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To A French Woman Infected With Ebola Virus 9/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Levalbuterol Inhalation Solution, USP 9/24/2014
Sagent Pharmaceuticals, Inc. Announces The Introduction Of Oxaliplatin Injection, USP 9/24/2014
Regeneron Pharmaceuticals, Inc. (REGN) R&D Chief Reveals Allergy Drug May Be Darling Of Its Pipeline 9/23/2014
Anacor Pharmaceuticals, Inc. (ANAC) Announces Commercial Launch Of KERYDIN (tavaborole) Topical Solution, 5% In The United States 9/23/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014
Lannett Company, Inc. (LCI) Launches Oxycodone Hydrochloride Oral Solution 9/22/2014
60 Percent Of New York’s Hep C Patients Will Get Gilead Sciences, Inc. (GILD)'s Sovaldi 9/19/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Ketorolac Tromethamine Injection, USP 9/18/2014
Roche (RHHBY) Introduces A New Fertility Test For Assessment Of Ovarian Reserve For Pregnancy 9/18/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV 9/17/2014
New Product From Vireo Systems: pH-D Feminine Health Support 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Bayer HealthCare (BAY) Announces The Launch Of Aleve® PM: The First And Only OTC PM Pain Reliever With A Sleep Aid Plus The 12-Hour Pain Relieving Strength Of Aleve 9/15/2014
Easton Pharmaceuticals (OP: EAPH) Announces Preparations For North American Product(s) Launch 9/15/2014
Roche (RHHBY) Battles Counterfeit Rituxin Vials In Germany 9/15/2014
The Medicines Company (MDCO) To Review ORBACTIV™ (Oritavancin) Launch Readiness On Tuesday, September 16, 2014 9/12/2014
The Obesity Society Release: New FDA-Approved Weight Loss Drug Adds New Tool For Obesity Treatment 9/11/2014
EMD Serono Canada Inc. Announces Launch Of The Eeva® Test In Canada 9/11/2014



//-->